Nov 01, 2024 Life sciences M&A roundup: October 2024 By Ross McNaughton Sarah Cole We have seen a general plateauing of biotech M&A in the last few months, but we've kept tabs on a few deals of note in October, keeping...
Oct 09, 2024 UK government launches new Regulatory Innovation Office to reduce red tape By Debbie Heywood On 8 October 2024, acting on a manifesto commitment, the UK's Department for Science, Innovation and Technology, announced the launch of...
Sep 27, 2024 Life sciences M&A roundup: September 2024 By Ross McNaughton Sarah Cole After a spate of summer announcements, biotech M&A has taken a break in September with only a handful of deals reported and only one with...
Sep 25, 2024 Spotlight on medical devices: FDA, MHRA and EU Commission approaches to medical device regulations By Nick Vollers We were pleased to host Jennifer D. Newberger (Hyman Phelps & McNamara), Jenifer Hannon (BSI) and Sue Spencer (QServe) for a panel...
Sep 18, 2024 Advertising medical devices: lack of harmonisation across Europe By Alice Matthews At our recent Spotlight on medical devices event, Taylor Wessing's European team discussed the differing approaches taken to the...
Sep 04, 2024 Life sciences M&A roundup: August 2024 By Ross McNaughton Sarah Cole It's been a busy month for life sciences M&A, with a notable focus on smaller deals over blockbusters. Key themes throughout August...
Aug 08, 2024 Supply chain control: what medical device manufacturers need to know By Alison Dennis Paolo Palmigiano The EU and UK medical device laws require manufacturers to establish a system of communication with other economic operators and...
Aug 01, 2024 Life sciences M&A roundup: July 2024 By Ross McNaughton Sarah Cole Here's the latest biopharma M&A update for July. Our overall feeling was of a subdued market with only a handful of announced biotech...
Jul 09, 2024 Transfers of value: the disclosure trap By Alison Dennis On 5 July 2024, Novo Nordisk (NN), received its second public reprimand from the PMCPA in 18 months. The reprimand relates to a voluntary...
Jul 01, 2024 Life sciences M&A roundup: June 2024 By Ross McNaughton Sarah Cole A relatively quiet month for life sciences M&A, though with some interesting deals announced for Johnson & Johnson, AbbVie and GSK. We...
Mar 07, 2024 Spring Budget 2024: further tax relief changes "when fiscal conditions" allow for Life Sciences businesses By Sally Robertson Jeremy Hunt’s Spring Budget 2024 has not revealed any new significant changes to relevant tax reliefs following his Autumn Statement in...